A Study of Brenipatide in Adult Participants With Schizophrenia
for Schizophrenia
32 locations incl. Little Rock
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 55
Code: NCT07410507·Phase 2·Recruiting·Listed Feb 2026
RE:Cognition (Chicago)
Clinical research site in Chicago, Illinois · 820 S DAMEN AVE, CHICAGO, IL 60612-3728 · (608) 821-7200 · Website
5.0on Google· View on Google Maps
As of September 2026, 9 paid clinical trials are recruiting at RE:Cognition (Chicago) in Chicago, Illinois. Active studies at this site cover conditions such as Schizophrenia, Opioid Use Disorder and Alzheimers Disease. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
New trial at RE:Cognition (Chicago)? We'll email you when one opens.
Recruiting clinical trials at RE:Cognition (Chicago) (9)
A Study of Brenipatide in Participants With Opioid Use Disorder
for Opioid Use Disorder
38 locations incl. Phoenix
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 75
Code: NCT07420283·Phase 2·Recruiting·Listed Feb 2026
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
for Alzheimers Disease
67 locations incl. Birmingham
Sponsor: Hoffmann-La Roche
Sex: All·Age: 50 - 90
Code: NCT07177352·Phase 3·Recruiting·Listed Sep 2025
A Study of Brenipatide in Participants With Alcohol Use Disorder
for Alcohol Use Disorder
29 locations incl. Scottsdale
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 75
Code: NCT07219953·Phase 3·Recruiting·Listed Oct 2025
A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder
for Alcohol Use Disorder
30 locations incl. Birmingham
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 75
Code: NCT07219966·Phase 3·Recruiting·Listed Oct 2025
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
for Alzheimers Disease
35 locations incl. Birmingham
Sponsor: Hoffmann-La Roche
Sex: All·Age: 50 - 90
Code: NCT07169578·Phase 3·Recruiting·Listed Sep 2025
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
for Alzheimer's Disease
25 locations incl. Long Beach
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 60 - 85
Code: NCT06976216·Phase 3·Recruiting·Listed May 2025
An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome
for Lennox Gastaut Syndrome
17 locations incl. Miami
Sponsor: Epygenix
Sex: All·Age: 2 - 55
Code: NCT05066217·Phase 3·Recruiting·Listed Oct 2021
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
for Focal Seizure
11 locations incl. Huntsville
Sponsor: Rapport Therapeutics Inc.
Sex: All·Age: 18 - 75
Code: NCT07594119·Phase 3·Recruiting·Listed May 2026
Get new-trial alerts for RE:Cognition (Chicago)
We'll email you whenever a new clinical trial starts recruiting at this research site in Chicago, IL. Unsubscribe anytime.
More research sites in Chicago
- Northwestern University (334 trials)
- University of Chicago (186 trials)
- Rush University Medical Center (158 trials)
- Ann & Robert H. Lurie Children's Hospital of Chicago (111 trials)
- University of Chicago Medical Center (98 trials)
- University of Chicago Comprehensive Cancer Center (86 trials)
- University of Illinois (83 trials)
- Northwestern Memorial Hospital (81 trials)
- University of Illinois at Chicago (71 trials)
- Advocate Illinois Masonic Medical Center (47 trials)
Is this your research site?
This page is built from public ClinicalTrials.gov records. If you work here, we can correct it, send you the patients who apply, and build you a free website from your real studies — verify it with your work email, or read what we do for research sites.
Explore more
Paid clinical trials in Chicago, IL · Illinois clinical trials